Back to News
Market Impact: 0.2
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP announced that a class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR). The release provides no allegations, claimed damages, filing period, or operational details, but the litigation introduces a potential legal and investor-sentiment overhang for the biotech company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CAPR-0.85
More News
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- J&J prostate cancer drug shows promising tumor responses in early trial
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- Meta shares are down 9% this week. Here's why Mike Khouw is buying now